ZM 447439 - Bio-Techne
Inrebic (fedratinib) - BMS
lenalidomide - Generic mfg.
seliciclib (CYC202) - Cyclacel, Cedars-Sinai
PHA 793887 - Nerviano Medical Sciences
AT7519 - Novartis, Otsuka
gemcitabine - Generic mfg.
Jakafi oral (ruxolitinib) - Novartis, Incyte
navitoclax (ABT 263) - AbbVie
obatoclax (GX 15-070) - Teva
tozasertib (MK-0457) - Merck (MSD)
https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=150405
 
Xianhuo Wang, M.D.1; Yaxiao Lu, M.D.1; Yue Fei, M.D.1; Lanfang Li, M.D.1; Lihua Qiu, M.D.1; Zhengzi Qian, M.D.1; Shiyong Zhou, M.D.1; Kai Fu, M.D., Ph.D.2; Huilai Zhang, M.D.1
 
Nov 5, 2021
 
Prev Next